The World Health Organization (WHO) on 24 September recommended the synthetic antibody treatment Regeneron for COVID-19, but only in patients with specific health profiles. Individuals with non-severe COVID-19, who are still at high risk of hospitalization, may take the antibody combo, as should critically ill patients unable to mount an adequate immune response, according to WHO According to a discovery published in bmj.
Read | Rules affecting the medical infrastructure of the state
you can track coronavirus Cases, deaths and testing rates at the national and state levels Here. List state helpline number also available.
here are the events:
National
COVID-19 vaccination at home for the disabled: Center
The Health Ministry said on 23 September that people with restricted mobility, disabilities and special needs can avail COVID vaccination at home by following all safety protocols.
NITI Aayog Member (Health) VK Paul said that India has already achieved the milestone of immunizing 66% of its adult population with a single dose of vaccines.
“The Health Ministry aims to provide maximum vaccine cover to as many people as possible and this is an important step in this endeavour. People who do not have adequate mobility, and cannot even access vaccination facility near home, can be covered under this programme. We have made provision for home vaccination under supervision especially for this group of persons,” said Dr Paul.
America
US CDC advisory recommends COVID-19 vaccine boosters for people age 65 and older at high risk
On September 23, a US Centers for Disease Control and Prevention (CDC) advisory panel recommended a booster shot of the Pfizer and BioNTech COVID-19 vaccine for Americans 65 and older and some adults with underlying medical conditions, allowing them to be at risk of serious illness. .
The panel declined to recommend boosters for adults aged 18 to 64 who live or work in institutions at high risk of contracting COVID-19, such as healthcare workers, based on individual exposure. , teachers and residents of homeless shelters and prisons. Some panel members cited difficulty in implementing such a proposal. – Reuters
International
WHO backs Regeneron COVID-19 drug cocktail as UN body calls for equal access
A World Health Organization (WHO) panel on September 24 recommended the use of Regeneron and Roche’s COVID-19 antibody cocktail for patients at high risk of hospitalization and critically ill people with no natural antibodies.
The treatment was given US emergency use authorization last year when it was used to treat former President Donald Trump’s COVID-19 illness. Europe is reviewing the therapy, while the UK approved it last month. – Reuters
Delhi
6th serosurvey to start in Delhi; 28,000 samples will be taken
According to an official order, the Delhi government will launch the sixth serological survey on September 24 to find out what percentage of the population has antibodies against COVID-19 through natural infection or vaccination. The government aims to collect 28,000 blood samples of random people from all the 272 wards of the city for the survey.
The government had started the sixth serological survey in April, but due to the second wave, it had to be cut. Despite the team submitting the results to the government, the government never made public the results of over 12,000 samples collected in April.
China tests Indian seafood for COVID-19 virus online
China, which suspended imports of frozen seafood products citing the presence of the COVID-19 virus, began inspecting stocks at Indian processing plants and export units.
After finding traces of nucleic acids on the packaging of seafood, China rejected marine products shipped from India citing the threat of COVID-19, besides blacklisting some international exporters a few months ago. More than 500 seafood containers have been stranded at Chinese ports for several days.
.